CAS RN: 1926172-50-0
4-Bromo-5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260410 |
100mg / 250mg / 1g / 5g / 25g |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 10g, 25g, 5g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1926172-50-0
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
3
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>97% |
3
In Stock
|
Hong Kong |
Inquiry |
| 1g |
>97% |
3
In Stock
|
Shanghai |
Inquiry |
| 10g |
>97% |
2
In Stock
|
Hong Kong |
Inquiry |
| 25g |
>97% |
2
In Stock
|
Shanghai |
Inquiry |
| 5g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
1926172-50-0 / 4-bromo-5-methyl-1-(oxan-2-yl)indazole
Standard CAS: 1926172-50-0
Multi CAS: No
Basic Information
CAS
1926172-50-0
Multi CAS
No
Molecular Formula
C13H15BrN2O
Molecular Weight
295.170000
Exact Mass
294.036780
SMILES
CC1=C(C2=C(C=C1)N(N=C2)C3CCCCO3)Br
InChI
InChI=1S/C13H15BrN2O/c1-9-5-6-11-10(13(9)14)8-15-16(11)12-4-2-3-7-17-12/h5-6,8,12H,2-4,7H2,1H3
InChIKey
QYBLJMHBINRKQM-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
17
Aromatic heavy atom count
9
Fraction Csp3
0.46
Rotatable bonds
1
H-bond acceptors
3
Molar refractivity
71.01
TPSA
27.05
LogP / Solubility
WLOGP
3.81
MLOGP
3.36
XLogP3
3.4
Consensus LogP
3.52
Log S (ESOL)
-4.39
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.73
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.86
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.82
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2